Clinical Trials · NCT05633966
Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Stephanie B. Seminara, MD
- Enrollment
- 13
- Start date
- Dec 2022
- Locations
- 1 site, United States
- Primary endpoint
- The proportion of participants that achieve development of a mature follicle or show evidence of ovulation